Redefining PV Skillsets in an AI-Driven World: Training the Next Generation of Safety Scientists
As AI becomes embedded across pharmacovigilance, the skills required of safety scientists are rapidly evolving. This article examines the shifting balance between human expertise and AI-enabled tools, outlining the competencies, training pathways, and cultural changes needed to prepare tomorrow’s hybrid PV workforce.
Old Medicine, New Frameworks: the Often Overlooked Mind-Body Connection with Therapeutic Psychedelics
The history of depression treatment reflects a centuries-old tension between mind and body—and how we conceptualize the condition has always shaped how we treat it. Today, with up to 30% of patients classified as treatment-resistant, psychedelic-assisted therapies are attracting serious scientific and regulatory attention. But emerging evidence suggests that the therapeutic context surrounding these treatments—relationships, setting, and social environment—may matter as much as the compounds themselves.
Smarter than AI: A Commentary on Serendipitous Drug Discovery
One in four drugs traces its origin to serendipity—unexpected discoveries that changed medicine forever. From penicillin to GLP-1s now projected to reach $100 billion by 2030, the most transformative treatments often emerge when researchers pay attention to “off-target” effects. As AI reshapes drug development, human observation and patient-centered design remain our most powerful tools for breakthrough discoveries.
Navigating 2026: Patient service themes, challenges, and solutions
As we look ahead to 2026, patient access and support services face growing complexity—from affordability challenges and evolving care models to the rise of specialty therapies. This blog explores the key trends shaping the healthcare landscape and offers strategic solutions, including AI-powered innovation, digital transformation, and partnerships that drive better outcomes. Discover how UBC is leading the way with patient-first strategies to simplify the patient and product journey.
Navigating the AI Landscape: Choosing the Right Model for Your PV Needs
AI is no longer just a buzzword—it’s a practical tool shaping how we work every day. Learn how UBC leverages AI models to streamline tasks, enhance decision-making, and maintain compliance.
Redefining Real-World Data: How Datavant Scales Medical Record Retrieval for Complete, Connected Insights
Modern medical record retrieval is transforming real-world evidence. Datavant’s approach combines nationwide reach, deep data connectivity, and high record yields to deliver comprehensive, research-ready datasets.
2025 NORD Rare Disease Summit: Advancing Evidence and Partnerships for the Rare Community
UBC attended the 2025 NORD Rare Diseases & Orphan Products Breakthrough Summit, where patient voices, scientific innovation, and regulatory expertise converged to shape the future of rare-disease research. Learn what inspired us and how we’re advancing real-world evidence, patient partnerships, and innovative trial designs to accelerate progress for the rare-disease community.
High-Touch, High-Impact: Optimizing Patient Support in Cell & Gene Therapy
As cell and gene therapies reshape treatment paradigms, patient support programs must evolve to meet new challenges. Discover how strategic alignment, payer advocacy, and innovative solutions can optimize the patient journey.
Registry feasibility assessments for post-authorization safety studies (PASS): Learnings and Challenges
UBC recently completed a multi-country feasibility assessment to identify disease registries capable of supporting a PASS for a novel therapy targeting a hereditary muscular disorder. The study evaluated registry data elements, quality, and governance to ensure fit-for-purpose real-world data (RWD) for generating reliable RWE.
